PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY AIMED AT VALIDATING A PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN HIGH-RISK NEUROBLASTOMA PATIENTS

被引：0
|
作者：
Nishimura, Noriyuki [1 ]
Ishida, Toshiaki [2 ]
Yokota, Isao [2 ]
Matsumoto, Kimikazu [2 ]
Shichino, Hiroyuki [2 ]
Kamijo, Takehiko [2 ]
Takimoto, Tetsuya [2 ]
Iehara, Tomoko [2 ]
Tajiri, Tatsuro [2 ]
机构：
[1] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo, Japan
[2] Japan Childrens Canc Grp JCCG Neuroblastoma Comm, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS2-1
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [31] The COSTA Study: Sternal Closure in High-Risk Patients - A Prospective Randomized Multicenter Trial
    Leinberger, Tetyana
    Heilmann, Claudia
    Sorg, Stefan
    Mueller, Matthias
    Kueri, Sami
    Schmoor, Claudia
    Siepe, Matthias
    Beyersdorf, Friedhelm
    THORACIC AND CARDIOVASCULAR SURGEON, 2018, 66 (06): : 508 - 516
  • [32] PROGNOSTIC SIGNIFICANCE OF METASTATIC MIBG-POSITIVE DISEASE SITES AT DIAGNOSIS IN HIGH-RISK NEUROBLASTOMA PATIENTS
    Sokol, Elizabeth
    Rossoff, Jenna
    Gosiengfiao, Yasmin
    Cohn, Susan
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [33] The Addition of Venetoclax to Ibrutinib Achieves a High Rate of Undetectable Minimal Residual Disease in Patients with High-Risk CLL
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Jain, Nitin
    Wang, Yan
    Peterson, Christine B.
    Garg, Naveen
    Wei, Chongjuan
    Ayala, Ana
    Kadia, Tapan M.
    Bose, Prithviraj
    Pemmaraju, Naveen
    Short, Nicholas J.
    Keating, Michael J.
    Wierda, William G.
    BLOOD, 2020, 136
  • [34] Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational study
    Noriaki Manabe
    Takashi Joh
    Kazuhide Higuchi
    Katsuhiko Iwakiri
    Takeshi Kamiya
    Ken Haruma
    Koji Nakada
    Scientific Reports, 12
  • [35] Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational study
    Manabe, Noriaki
    Joh, Takashi
    Higuchi, Kazuhide
    Iwakiri, Katsuhiko
    Kamiya, Takeshi
    Haruma, Ken
    Nakada, Koji
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia
    Lacombe, Francis
    Campos, Lydia
    Allou, Kaoutar
    Arnoulet, Christine
    Delabarthe, Adrienne
    Dumezy, Florent
    Feuillard, Jean
    Genevieve, Franck
    Guerin, Estelle
    Guy, Julien
    Jouault, Helene
    Lepelley, Pascale
    Maynadie, Marc
    Solly, Francoise
    Ballon, Orianne Wagner
    Preudhomme, Claude
    Baruchel, Andre
    Dombret, Herve
    Ifrah, Norbert
    Bene, Marie C.
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (02) : 422 - 428
  • [37] Significance of Molecular-Biological Prognostic Factors in High-Risk Neuroblastoma Patients
    Shorikov, E.
    Druy, A.
    Zaychikov, A.
    Chusovitin, D.
    Popova, T.
    Lemesheva, O.
    Vyatkin, I.
    Tuponogov, S.
    Tsaur, G.
    Popov, A.
    Saveliev, L.
    Fechina, L.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S203 - S203
  • [38] Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood
    San Lin, Kyaw
    Uemura, Suguru
    Thwin, Khin Kyae Mon
    Nakatani, Naoko
    Ishida, Toshiaki
    Yamamoto, Nobuyuki
    Tamura, Akihiro
    Saito, Atsuro
    Mori, Takeshi
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    Nino, Nanako
    Nagano, China
    Takafuji, Satoru
    Iijima, Kazumoto
    Nishimura, Noriyuki
    TRANSLATIONAL ONCOLOGY, 2021, 14 (08):
  • [39] Detection of Minimal Residual Disease (MRD) in High Risk Neuroblastoma Correlates with Outcome: Final Results of International GPOH-DCOG Prospective Validation Study
    Van Zogchel, L.
    De Carolis, B.
    van Wezel, E.
    Stutterheim, J.
    Zappeij-Kannegieter, L.
    van Doornum, M.
    Schumacher-Kuckelkorn, R.
    Gecht, J.
    Simon, T.
    Caron, H.
    Fiocco, M.
    van der Schoot, E.
    Hero, B.
    Berthold, F.
    Tytgat, G.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S38 - S38
  • [40] Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease
    Desai, Ami, V
    Applebaum, Mark A.
    Karrison, Theodore G.
    Oppong, Akosua
    Yuan, Cindy
    Berg, Katherine R.
    MacQuarrie, Kyle
    Sokol, Elizabeth
    Hall, Anurekha G.
    Pinto, Navin
    Wolfe, Ian
    Mody, Rajen
    Shusterman, Suzanne
    Smith, Valeria
    Foster, Jennifer H.
    Nassin, Michele
    LaBelle, James L.
    Bagatell, Rochelle
    Cohn, Susan L.
    CANCER, 2022, 128 (15) : 2967 - 2977
12345